COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS

Slides:



Advertisements
Similar presentations
Elicitation methods Health care demands exceed resource supply Therefore, rationing is inevitable Many ways by which we can ration health care One is economic.
Advertisements

ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
Design of the fast-pick area Based on Bartholdi & Hackman, Chpt. 7.
Hawawini & VialletChapter 7© 2007 Thomson South-Western Chapter 7 ALTERNATIVES TO THE NET PRESENT VALUE RULE.
Issues in Capital Budgeting II
We show that MP can be used to allocate resources to treatments within and between patient populations, using a policy-relevant example. The outcome is.
Decision Analysis. What is decision analysis? Based on expected utility theory Based on expected utility theory Used in conditions of uncertainty Used.
Review of Barrier Free Approach and Additional Analysis of MEPS Data Related to ‘Potential’ vs. ‘Experienced’ Barriers.
Alternative antiretroviral monitoring strategies for HIV-infected patients in resource-limited settings: Opportunities to save more lives? R Scott Braithwaite,
Utility Assessment HINF Medical Methodologies Session 4.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
(c) 2001 Contemporary Engineering Economics 1 Chapter 17 Economic Analysis in the Public Sector Framework of Benefit- Cost Analysis Valuation of Benefits.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /4/2002.
317_L25, Mar J. Schaafsma 1 Review of the Last Lecture Have discussed three methods for shadow pricing life and limb for CBA: human capital method,
A RECIPE FOR INCOHERENCE: AVERAGING TIME-TRADEOFF OR STANDARD-GAMBLE UTILITIES ACROSS HEALTH ATTRIBUTES Gordon B. Hazen, IEMS Department, Northwestern.
Decision Trees Farrokh Alemi, Ph.D.. Coming Up How to construct a decision tree? –Components of a tree –Interviewing decision makers How to analyze a.
AGEC 608 Lecture 02, p. 1 AGEC 608: Lecture 2 Objective: Review conceptual foundations of CBA Readings: –Boardman, Chapter 2 –Kankakee, Sections I and.
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
1 Cost-Effectiveness Analysis (CEA) Scott Matthews Courses: and Lecture /3/2003.
Schneider Institute for Health Policy Heller Graduate School Brandeis University September by Donald S. Shepard, Ph.D. Schneider Institute for Health.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
1 Cost-Utility Analysis Cost-Effectiveness Analysis Scott Matthews Courses: / / Lecture /9/2005.
Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment.
POST- RANDOMIZATION DATA ANALYSIS OGNEN JAKASANOVSKI
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Measuring and valuing health outcome Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Chapter 13 Capital Budgeting Techniques. Learning Objectives After studying Chapter 13, you should be able to: Understand the payback period (PBP) method.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Taxes on the Longevity Dividend: Can we Reduce Them? Lessons from the Theoretical Foundations of Medical Cost-Effectiveness Analysis David Meltzer MD,
Chapter 6 Economic Concepts: Behind The Accounting Numbers Mark Higgins Chapter 6 Economic Concepts: Behind The Accounting Numbers Mark Higgins.
Measuring Health Outcomes
Evaluation of Medicine Two types: –Societal level Economic evaluation –Individual level medical decision making.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 9: Cost-utility analysis – Part 2.
Economic evaluation Definition - the comparative analysis of alternative courses of action in terms of both their cost and consequences.
317_L26, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare Three methods: CBA, CEA, CUA discussed CBA,
Estimating Outcomes in Decision Analysis Brian Harris MPP Candidate Goldman School of Public Policy University of California, Berkeley.
Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia Program Evaluation from an Economic Perspective.
Measuring Efficiency CRJS 4466EA. Introduction It is very important to understand the effectiveness of a program, as we have discovered in all earlier.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
CHAPTER 12 Descriptive, Program Evaluation, and Advanced Methods.
PHARMACOECONOMIC EVALUATIONS & METHODS MARKOV MODELING IN DECISION ANALYSIS FROM THE PHARMACOECONOMICS ON THE INTERNET ®SERIES ©Paul C Langley 2004 Maimon.
Sample Size Determination in Studies Where Health State Utility Assessments Are Compared Across Groups & Time Barbara H Hanusa 1,2 Christopher R H Hanusa.
Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research.
Consumer Behavior 06 McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Budget Impact Analysis: Methods & Data Mark W. Smith, PhD VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park, CA
Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment.
Evaluation of Low Volume Roads Rodrigo Archondo-Callao Senior Highway Engineer, ETWTR January 10, 2008 The World Bank.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
EBM --- Journal Reading Presenter :葉麗雯 Date : 2005/10/27.
Cost and Benefits. Introduction Is treatment X worth it?
Farid Abolhassani Markets and Efficiency 10. Learning Objectives After working through this chapter, you will be able to: List and describe the assumptions.
Section VI Capital Rationing. Section Highlights F Capital rationing F Linear programming F Shadow prices and the cost of capital F Integer programming.
CRJS 4466 PROGRAM & POLICY EVALUATION LECTURE #6 Evaluation projects Questions?
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 7: Cost-effectiveness analysis – Part.
 This will explain how consumers allocate their income over many goods.  This looks at individual’s decision making when faced with limited income and.
IE 485 «Decision Making in Health Care»
Preference Assessment 1 Measuring Utilities Directly
Sergio Bautista-Arredondo National Institute of Public Health Mexico
Behind The Accounting Numbers
Assessing value for money: principles, methods and issues
Economic Problems 4/18/2019.
Measuring outcomes Emma Frew October 2012.
Elicitation methods Health care demands exceed resource supply
Presentation transcript:

COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS CHAPTER 17: COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS

Purpose: Cost-effectiveness Analysis (CEA) and cost-utility Analysis (CUA) are often used instead of CBA when analysts are unable or unwilling to monetize the major policy impact (e.g., lives saved or national defense).

Cost-effectiveness Analysis Compares (mutually exclusive) alternatives on the basis of the ratio of their costs and a single quantified but not monetized effectiveness measure, such as dollars per lives saved. Programs that cost less per life saved are more efficient than other programs.

Cost-effectiveness Analysis Since CEA involves two metrics (cost and an effectiveness measure) one cannot obtain a single measure of social net benefits; one can only compute the ratio of the two. This can be done in two ways: cost per unit of outcome effectiveness or outcome effectiveness per unit cost

Cost per unit of outcome effectiveness CEi = Ci/Ei = average cost per unit of effectiveness Lower is better

Outcome effectiveness per unit cost ECi = Ei/Ci = average effectiveness per unit cost Bigger is better Both are good measures of technical efficiency

Measurement of Costs Varies enormously. Preferable to include all social costs, although costs that are constant across all alternatives can be omitted because this will not change the CE rankings, although it will change the CE ratios. In the health care area: cost of medication other treatment costs, such as doctors’ time or hospitalization waiting time or time lost from work, which are borne by patients or employers.

CEA Where Scale Problems Are Irrelevant: Identical Program Budgets or Identical Program Effectiveness Cost effectiveness ratios do not take different scales of projects into account. not a problem if all alternatives have the same cost (fixed budget) or if all alternatives have the same level of effectiveness (fixed effectiveness) But if the scales differ, it is not clear which project is best.

Imposing Constraints to Deal with Scale Differences In order to use CEA for decision making a common practice is to impose a constraint, either a minimum acceptable level of effectiveness or a maximum acceptable cost. If we impose a minimum level of effectiveness, we may either minimize costs, Ci, or the cost-effectiveness ratio, CEi. If we impose a maximum cost, we could either maximize effectiveness or minimize the cost-effectiveness.

Cost-utility analysis Also relates costs to a single benefit measure, but the benefit measure is a construct made up of several (usually two) benefit categories, reflecting both quantity and quality. As CUA measures both quantity and quality of impacts, it comes a step closer to CBA than CEA

For example The benefit measure may be quality-adjusted life-years (QALY), which combines both the number of additional years of life and the quality of life during those years. Programs are compared on the basis of dollars per quality-adjusted life-year, $/QALY.

The Meaning of Life – Quality-Adjusted Life-Years, That Is! QALY combines two distinct variables – quality (health status) quantity (years) of health There are three common methods for deriving utility-like measures of health status or QALYs:

Formulating a Health Status Index and Measuring QALYs Health rating method. This derives health ratings from questionnaires with health experts, potential subjects of treatment, or members of society in general. Individuals are asked to assign values between 0 and 1 to various (well-described) health states.

Formulating a Health Status Index and Measuring QALYs Time trade-off method. Respondents asked to compare different combinations of length and quality of life. The trade-offs in the responses provide a basis for ranking various states (in quality and years)

Formulating a Health Status Index and Measuring QALYs Standard gamble method. Respondents are presented with a decision tree with two alternatives like the following: one alternative is impaired health for t years; the other is normal health for n years with probability p or immediate death with probability 1-p. The p at which an individual is indifferent can be interpreted as the respondent’s utility of the former alternative.

Standard gamble method

Issues related to QALY are not all resolved: Discounting is somewhat problematic as one cannot trade off near years of health for far years of health (and vice versa). Since methods are based on questionnaires, there may be hypotheticality problems (respondents simply haven’t thought about the issues very much) sample selection problems (potential treatment candidates might exaggerate the “utility” they would receive from a better health state following treatment) framing effects (i.e. how questions are asked).